Geode Capital Management
TTHI

Geode Capital Management’s TRANSITION THERAPEUTICS INC (CANADA) TTHI Stock Holding History

Geode Capital Management’s Portfolio TTHI Stock Details TTHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-12,651
Closed -$18K – 4130
2016
Q2 		$18K Hold
12,651
– – ﹤0.01% 4035
2016
Q1 		$16 Sell
12,651
-111
-0.9% -$128 ﹤0.01% 4070
2015
Q4 		$24K Buy
12,762
+222
+2% +$421 ﹤0.01% 4085
2015
Q3 		$22K Buy
12,540
+222
+2% +$472 ﹤0.01% 4086
2015
Q2 		$25K Buy
12,318
+111
+0.9% +$778 ﹤0.01% 3927
2015
Q1 		$83K Buy
+12,207
New +$84.3K ﹤0.01% 3789

Other funds holding TTHI

HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Geode Capital Management's TTHI Position: Q3 2016 in Review

Geode Capital Management sold out of TRANSITION THERAPEUTICS INC (CANADA) (TTHI) in Q3 2016, closing a stake of 12,651 shares — an estimated $18K sold.

Geode Capital Management first reported a position in TTHI in Q1 2015 and held it in 6 quarters. The position peaked at $83K in Q1 2015. 2 funds tracked by Wall St. Rank hold TTHI as of Q3 2016.

  • Geode Capital Management reported no remaining TRANSITION THERAPEUTICS INC (CANADA) position as of Q3 2016 after selling out during the quarter.
  • Geode Capital Management sold 12,651 TRANSITION THERAPEUTICS INC (CANADA) shares in Q3 2016, an estimated $18K.
  • Geode Capital Management first reported a position in TRANSITION THERAPEUTICS INC (CANADA) in Q1 2015 and held it in 6 quarters.
  • Geode Capital Management's TRANSITION THERAPEUTICS INC (CANADA) position peaked at $83K in Q1 2015.
  • 2 funds tracked by Wall St. Rank held TRANSITION THERAPEUTICS INC (CANADA) as of Q3 2016.

Based on Geode Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.